Description: Agilent Technologies, Inc. provides bio-analytical and electronic measurement solutions and services to the life sciences, chemical analysis, diagnostics and genomics, communications, and electronics industries worldwide. The company's Life Sciences segment offers liquid chromatography systems, columns, and components; liquid chromatography mass spectrometry systems; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; nucleic acid solutions; and nuclear magnetic resonance, magnetic resonance imaging, and X-ray diffraction systems. Its Chemical Analysis segment provides gas chromatography systems, columns, and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; inductively coupled plasma optical emission spectrometry instruments; molecular spectroscopy instruments; software and data systems; and vacuum pumps and measurement technologies. The company's Diagnostics and Genomics segment offers immunohistochemistry, in situ hybridization, hematoxylin and eosin staining, special staining, DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, and DNA methylation and gene expression profiling, as well as automated gel electrophoresis-based sample analysis systems. Its Electronic Measurement segment provides electronic measurement instruments and systems, software design tools, and related services used in the design, development, manufacture, installation, deployment, and operation of electronics equipment and microscopy products. This segment's products include communications and general purpose test products. Agilent Technologies, Inc. sells its products through direct sales representatives; and distributors, resellers, manufacturer's representatives, telesales, and electronic commerce. The company was founded in 1999 and is headquartered in Santa Clara, California.
Home Page: www.agilent.com
A Technical Analysis
5301 Stevens Creek Boulevard
Santa Clara,
CA
95051
United States
Phone:
800 227 9770
Officers
Name | Title |
---|---|
Mr. Michael R. McMullen | CEO, Pres & Director |
Mr. Robert W. McMahon | Sr. VP & CFO |
Mr. Jacob Thaysen | Sr. VP and Pres of Life Sciences & Applied Markets Group |
Mr. Samraat S. Raha | Sr. VP and Pres of Diagnostics & Genomics Group |
Mr. Padraig McDonnell | Sr. VP & Pres of Agilent Cross Lab Group |
Mr. Rodney Gonsalves | Principal Accounting Officer, VP & Corp. Controller |
Dr. Darlene J. S. Solomon Ph.D. | CTO & Sr. VP |
Mr. Michael Tang | Sr. VP, Gen. Counsel & Sec. |
Mr. Dominique P. Grau | Sr. VP of HR & Global Communications |
Ms. Allison Ballmer | Sr. VP of Strategy & Corp. Devel. |
Exchange: NYSE
Country: US : United States of America
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Life Sciences Tools & Services |
GIC Sub-Industry: | Life Sciences Tools & Services |
Forward PE: | 26.9542 |
---|---|
Trailing PE: | 35.2799 |
Price-to-Book MRQ: | 8.6347 |
Price-to-Sales TTM: | 6.4988 |
IPO Date: | 1999-11-18 |
Fiscal Year End: | October |
Full Time Employees: | 18100 |